Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03800030 · ClinicalTrials.gov registry record · NA

Effect of Cross Frequency tACS on Cognitive Control

A NA study of Executive Function and Cognitive Control, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
NA
Development phase
26
Enrollment target
1
Study location

NCT03800030 is a NA study of Executive Function and Cognitive Control that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 26 participants, below the 144-participant average among 5 other Executive Function trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03800030, a NA study of Executive Function and Cognitive Control, has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
NA
Development phase
26 participants
Enrollment target
1
Study location

Study Summary

Investigation of frequency specific transcranial alternating current stimulation on cognitive control signals in frontal cortex

Interventions

  • DEVICE Sham tACS
  • DEVICE Theta-gamma tACS
  • DEVICE Delta-beta tACS

Study Locations (1)

North Carolina

  • University of North Carolina, Chapel Hill - Chapel Hill

Trial Details

FieldValue
Enrollment Target 26 participants
Start Date 2018-10-07
Est. Completion 2019-07-25
Phase NA

What the Registry Record Tells You About NCT03800030

The ClinicalTrials.gov registry entry for NCT03800030 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 144-participant average among 5 other Executive Function trials with a reported enrollment target (82% lower). The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Executive Function appearing as the primary indexed condition, and to 3 interventions - of which Sham tACS is the first listed.

NCT03800030 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT03800030 about?

NCT03800030 is a clinical study titled "Effect of Cross Frequency tACS on Cognitive Control". Investigation of frequency specific transcranial alternating current stimulation on cognitive control signals in frontal cortex

What is the current status of trial NCT03800030?

This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2018-10-07. Estimated completion is 2019-07-25.

What conditions does trial NCT03800030 study?

This clinical trial studies the following conditions: Executive Function, Cognitive Control.

What interventions are being tested in trial NCT03800030?

The interventions under investigation include: Sham tACS (DEVICE), Theta-gamma tACS (DEVICE), Delta-beta tACS (DEVICE).

Who is sponsoring clinical trial NCT03800030?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03800030 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Executive Function

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.